Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
GlaxoSmithKline Builds Dungarvan Facility
GlaxoSmithKline is constructing a 2,500-square meter facility in Dungarvan, County Waterford, Ireland. The €23 million investment will provide space for granulation and compression operations for over-the-counter medicines.
Galway-Mayo Institute of Technology Constructs Nursing and Health Science Facility
The Galway-Mayo Institute of Technology (GMIT) began construction in February of 2007 on a new Department of Nursing and Health Sciences in Castlebar, Ireland. Including the renovation of the west wing of the existing St. Mary’s Hospital, the €6-million project will house classrooms, theaters, a clinical skills laboratory, and a library.
Florida Atlantic University To Create New Academic Medical Center
Florida Atlantic University (FAU) is planning to construct the $400 million Charles E. Schmidt Medical Center on 38 acres of its Boca Raton campus. The new academic medical center will be created as a partnership between FAU, the University of Miami Miller School of Medicine, and Boca Raton Community Hospital.
City of New York Develops East River Science Park
The City of New York is partnering with Alexandria Real Estate Equities of Pasadena, Calif., to develop the 1.1 million-sf East River Science Park. Groundbreaking will commence in early 2007 on the $700-million mixed-use life science campus sited on 3.5 acres in Manhattan. The first 670,000-sf phase of the project will consist of two towers, the first housing laboratory, office, and conference space; the second tower will house laboratory and office space over ground-level retail.
Yale Plans West Campus
Yale University is developing the West Campus, an interdisciplinary research hub for disciplines including biology, chemistry, environmental science, and physics. Located on 136 acres in West Haven, Conn., the site was previously owned by Bayer and includes 17 buildings comprising 1.5 million-sf with 550,000-sf of biology and chemistry research laboratories. Renovations to the facilities will continue through summer of 2008 when initial occupancy will begin.